剂泰科技-P今日盘中大跌6.56%，引发了市场关注。
消息面上，该股自上市以来持续面临回调压力。作为全球AI药物递送第一股，公司目前仍处于商业化早期阶段，过去三年累计亏损较大且营收波动，其长期业绩增长前景尚需时间验证，这影响了投资者的短期信心。
此外，部分国际配售股份未设置禁售期，导致上市后持续面临获利了结压力。随着新股上市初期的市场热度加速消退，股价的承压回落态势得以延续。
剂泰科技-P今日盘中大跌6.56%，引发了市场关注。
消息面上，该股自上市以来持续面临回调压力。作为全球AI药物递送第一股，公司目前仍处于商业化早期阶段，过去三年累计亏损较大且营收波动，其长期业绩增长前景尚需时间验证，这影响了投资者的短期信心。
此外，部分国际配售股份未设置禁售期，导致上市后持续面临获利了结压力。随着新股上市初期的市场热度加速消退，股价的承压回落态势得以延续。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.